Gene617
BCS1L: BCS1 ubiquinol-cytochrome c reductase complex chaperone
Cite this record
ConductScience Library. BCS1L: BCS1 ubiquinol-cytochrome c reductase complex chaperone. Genes, record 617. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/617
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y276 | Mitochondrial chaperone BCS1 | 419 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents249
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260139247 A1 | 2026-05-21 | 572 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38902 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38903 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38904 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38905 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38906 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38910 | Q9Y276 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38911 | Q9Y276 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7646 | Q9Y276 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 7646 | Q9Y276 | Espacenet |
NIH grants659
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BCS1L papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| U01DK062453 | Colorado Center of Childhood Liver Disease ResearchNetwork | 4 | 2025 |
| ZIABC010319 | Structural Basis of Biological Membrane Protein Functions and Drug Resistance | 4 | 2025 |
| ZIABC010600 | AAA Proteins, Mechanisms of Their Functions and Related Diseases | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 3 | 2025 |
| R01EY010804 | Setting the Stage for Replacement of Mitochondrial Genes | 3 | 2025 |
| T32HL007576 | Training in Cardiovascular Research | 3 | 2025 |
| K12GM068524 | San Diego IRACDA Scholars Program | 2 | 2025 |
Source NIH's project files
Papers1,049
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification. | Bioengineered | 2026 | 42820766 | PubTator, text mining | PubMed |
| The Efficiency of Capillarys 2 Flex Piercing, Premier Resolution-HPLC, and VARIANT II-HPLC for Hemoglobin Constant Spring Detection. | Hemoglobin | 2026 | 42675926 | PubTator, text mining | PubMed |
| Genetic Screening of Patients With Inherited Fanconi Syndrome. | Kidney Int Rep | 2026 | 42282999 | PubTator, text mining | PubMed |
Characterization of Antimicrobial Resistance and Potential Zoonotic Risk in Uropathogenic Escherichia coli Isolated from Companion Animals, with Genomic Analysis of Virulence Determinants in a Representative Isolate. | Trop Med Infect Dis | 2026 | 42042961 | PubTator, text mining | PubMed |
| HBA2 Gene Conversion Disrupts Reverse Dot-Blot Hybridization Genotyping: A Prenatal Case of Non-Deletional α-Thalassemia Misdiagnosis. | Hemoglobin | 2026 | 41987528 | PubTator, text mining | PubMed |
| Immunoprecipitation-mass spectrometry reveals known and novel (NatC, BCS1L) antinuclear antibodies in rheumatoid arthritis. | RMD Open | 2026 | 41963076 | PubTator, text mining | PubMed |
| Activation of the protective arm of renin-angiotensin system enhances mitochondrial turnover improving respiration and decreasing integrated stress response in a human Complex III deficiency model. | bioRxiv | 2026 | 41929162 | PubTator, text mining | PubMed |
| Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality? | J Clin Pathol | 2026 | 41819800 | PubTator, text mining | PubMed |
| Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants. | J Dtsch Dermatol Ges | 2026 | 41814923 | PubTator, text mining | PubMed |
| Effects of hydroxybisphosphonates-conjugated sitafloxacin on fracture healing and skeletal growth in mice. | JBMR Plus | 2026 | 41783235 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/617
GET https://conductscience.org/api/genes/v1/617/patents?page=2